A new manuscript describing the sharing and re-use of data, along with challenges encountered and potential solutions, was just published by PrIMAVeRa consortium partners at the Andalusian Health Service.
February 2025
The paper “How to: share and reuse data - challenges and solutions from PrIMAVeRa project” describes the process of identifying and gathering datasets with anonymised individual patient-level data for secondary data analysis.
Through a systematic search the authors identified 108 eligible studies about antimicrobial resistant infections, of which eight have completed all legal requirements and shared their datasets. During this process the authors have mapped challenges and possible solutions in data sharing activities related to lack of researchers’ interest, cumbersome ethical and legal requirements, laborious data management procedures, specific requirements for public data access, and insufficient training and funding.
The data gathered will be used by the PrIMAVeRa consortium to develop mathematical models to assess the impact of vaccines and monoclonal antibodies on antimicrobial resistance (AMR), and is publicly available in the European Clinical Research Alliance on Infectious Disease epidemiology network platform (https://epi-net.eu/primavera/about/anonymized-individual-patient-data/).
The PrIMAVeRa consortium congratulates the authors and look forward to continuing the battle against AMR.
Read the publication:
Guedes M, Bazan A de la S, Rubio-Martín E, Pulido LB, Palomo V, Piljić A, et al. How to: share and reuse data - challenges and solutions from PrIMAVeRa project. Clinical Microbiology and Infection. 2025 Jan 25. DOI: https://doi.org/10.1016/j.cmi.2025.01.024
This work has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034420 (PrIMAVeRa). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. This communication reflects the author's view, and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.
Comentarios